Details

Titel

CNS Drug News

Ist Teil von

• CNS Drug News Newsletter, 2015 (4 MAY 2015)

Erscheinungsjahr

2015

Link zum Volltext

Beschreibungen/Notizen

• Industry Trend Analysis - Tecfidera Will Be Leading MS Drug In 2015 Industry Brief - Biotie Provides Update On Tozadenant Phase III Programme Industry Brief - FDA Accepts Zinbryta BLA For MS Industry Brief - FDA Accepts Filing Of Betaconnect For RRMS Patients Taking Betaseron Industry Brief - Forward Pharma Receives Decision To Grant From EPO For DMF Patent In Europe Industry Brief - Phase III Success For Synthon's Glatiramer Acetate Industry Brief - First Patient Enrolled In Laquinimod Phase II Study For PPMS Industry Brief - Phase II Study With NeuroSTAT For TBI Passes Safety Evaluation Industry Brief - Long-Term Data Presented From First Clinical Trial Of ReNeuron's SC Therapy For Stroke Industry Brief - GW Receives FDA ODD For CBD For NHIE Industry Brief - Development Of NeuroVive's NVP014 For Stroke Enters New Phase Industry Brief - Vanda Receives Positive CHMP Opinion On Hetlioz For Non-24 Industry Trend Analysis - US Generic Aripiprazole Competition Will Stress Otsuka's Reliance On Brexpiprazole Industry Brief - Follow-Up Announcement Made On Preliminary Findings From Lurasidone Phase III Study Industry Brief - Pain Therapeutics Resumes Responsibility For Remoxy Industry Brief - FDA Approves Ionsys For Acute Postoperative Pain Industry Brief - CoLucid Initiates First Phase III Pivotal Trial Of Lasmiditan In Migraine Industry Brief - Elite Launches Hydroxyzine In US; Completes Dosing In Two ELI-200 Studies Industry Brief - Study Strengthens Evidence Of Zubsolv's Therapeutic Value Industry Brief - Eisai Settles US Rufinamide Litigation With Glenmark Industry Trend Analysis - GW Remains A Risky Investment; Results In H215 Will Be Key Industry Brief - Two Additional US Patents Issued For Vivus' Qsymia Industry Brief - Isis Earns USD10mn Milestone Payment From Biogen Industry Trend Analysis - Biogen Will Continue To Gain Share Of MS Market Industry Brief - Pernix Closes Acquisition Of Zohydro ER Franchise